For most race teams, seeing your cars take second, third and fourth places in a season championship would be cause for ...

Zelluna Reaches Major Milestone with Manufacturing Process Established in Preparation for Clinical Entry of ZI-MA4-1, its Novel TCR-NK Therapy Targeting Solid Tumours Oslo, Norway, 22 April 2025 – ...

Download your copy now and drive the future of CAR-T and TCR therapies. Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we ...

IMA203 is an autologous, engineered T-cell receptor T-cell therapy (TCR T) that targets PRAME, an intracellular protein displayed as a peptide antigen on the surface of multiple solid tumors via ...

Full abstracts will be available on the ASCO website on May 22, 2025, at 5:00 pm ET. IMA203 is an autologous, engineered T-cell receptor T-cell therapy (TCR T) that targets PRAME, an intracellular ...

If it seems like just a week has passed since the Genesis Hypercar reveal, that’s because, well, it has. But the Korean automaker has wasted no time in getting the car’s radical new powertrain ...

NASCAR and Speedway Motorsports officials announced Wednesday the format for the 2025 NASCAR All-Star Race, including an expanded 250-lap main event, a new promoter’s caution rule, revisions to ...

Immatics N.V., a clinical-stage biopharmaceutical company, announced that it will present data on its lead cell therapy candidate, IMA203 TCR T-cell therapy targeting PRAME, at the upcoming 2025 ...

Oral Presentation Title: Phase 1 clinical update of IMA203, an autologous TCR-T targeting PRAME in patients with PD1 refractory metastatic melanoma Presenting author: Martin Wermke, MD Session ...

The 2020 TCR Europe runner-up moved to the TCR World Tour last year, ending the season 11 th overall after racing an Audi RS3 LMS TCR to a best finish of fourth in Marrakech. Filippi also won a TCR ...